Diagnostics - Research and Markets - RSS Feed

Cardiac Resynchronization Therapy (CRT) Devices Pipeline Technology and Market Forecasts to 2015

press@researchandmarkets.com — Tue, 17 Nov 2009 15:15:14 GMT

“Cardiac Resynchronization Therapy (CRT) Devices Pipeline Technology and Market Forecasts to 2015” report is an essential source of information and analysis on the global CRT devices market The report identifies the key trends shaping and driving the dynamism in the global CRT devices market The...

Peptic Ulcer Testing - A World Market Intelligence Report

press@researchandmarkets.com — Tue, 17 Nov 2009 10:36:17 GMT

The prevalence of peptic ulcers in developing, and underdeveloped countries is greater than in developed countries. The bacteria, helicobacter pylori (H. pylori), is found to be the main cause of peptic ulcer infections. It has also been established that ulcers might also occur due to anti-inflammatory drugs such as aspirin or ibuprofen. These drugs disturb the physiological balance of the body, and result in ulceration by reducing gastro-duodenal production of prostaglandins. In developed countries, where general living and sanitation conditions are hygienic, instances of peptic ulcers are low in comparison to developing countries.

These and other market data and trends are presented in "Peptic Ulcer Testing: A World Market Intelligence Report" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Monoclonal Antibody Based Products - Global Trends

press@researchandmarkets.com — Tue, 17 Nov 2009 10:36:17 GMT

Monoclonal antibodies represent one of the successes of the biotechnology industry along with a broad range of therapeutics and diagnostics. Monoclonal Antibody (MAb)-based products market is one of the fastest growing categories of the biopharmaceuticals industry. These products are of high significance for pharmaceutical industry, both in research as well as drug development activities. MAbs function as production repositories for developing drugs, and are used in the manufacture of highly specialized diagnostic products. Rapid technological advancements that enable antibodies to specifically target disease-causing cells are expected to boost prospects in the global therapeutic and diagnostic monoclonal antibodies market.

These and other market data and trends are presented in "Monoclonal Antibody-Based Products: Global Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

DNA Probes-Based Diagnostics - A Worldwide Market Review

press@researchandmarkets.com — Tue, 17 Nov 2009 10:36:17 GMT

DNA probes-based diagnostics is an emerging application area in the in-vitro diagnostics industry. DNA probes, popular across the medical diagnostics industry, determine the presence of a suspected disease caused by an organism or pathogen. Based on the amount of target DNA present, probes can be used either directly to detect target DNA, or indirectly target DNA through amplification that creates a number of copies of specific nucleotide. Increased automation of diagnostic tests, discovery of new diagnostic markets, rising investments in pharmaceutical and pharmacogenomics research, and advancements in DNA array technologies are major growth facilitators for the DNA probes-based diagnostic products market.

In the area of molecular in-vitro diagnostics, DNA based diagnostics represent the most attractive, and fast growing clinical diagnostics technology primarily due to high levels of reliability, sensitivity, and rapidity. Numerous technology breakthroughs in the area of DNA diagnostics include PCR-based techniques, DNA microarrays and microfluidics, fluorescent in situ hybridization (FISH), SNP detection, and DNA nanotechnology, among several others. Breaking from the realm of research, current applications of DNA diagnostics are becoming widespread, with millions of samples from blood, hair and tissues, being analyzed for the positive identification of pathogens and diseases.

These and other market data and trends are presented in "DNA Probes-based Diagnostics: A Worldwide Market Review" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Diabetes Diagnostics - A Global Market Perspective

press@researchandmarkets.com — Tue, 17 Nov 2009 10:36:17 GMT

Diabetes Diagnosis market is driven by a steady increase in the number of people diagnosed with diabetes, both in the developed and developing parts of the world, and increase in intensive management and treatment processes/procedures. Product categories such as blood glucose test strips, monitors, and lancet/lancet devices are expected to register significant growth rates. Market prospects continue to be relatively brighter in the hemoglobin A1c diagnostic device and electrochemical blood glucose test strips segment.

These and other market data and trends are presented in "Diabetes Diagnostics: A Global Market Perspective" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

HIV/AIDS Testing - World Review

press@researchandmarkets.com — Tue, 17 Nov 2009 10:36:16 GMT

Revolutionary developments in the field of HIV disease monitoring and management have had its direct impact on HIV testing market. Earlier considered a life threatening disease, HIV/AIDS has now emerged as a persistent condition that necessitates efficient disease management. Such a change has encouraged people to increasingly adopt HIV testing procedures, though the trend is pronounced in developed countries, and is gaining momentum in developing nations. Revolutionary changes in HIV disease monitoring and management have had a significant influence on the HIV testing market. New disease-progression study techniques such as genotyping and phenotyping, and advancements in viral load monitoring tests have significantly improved therapies offered to HIV/AIDS infected individuals.

These and other market data and trends are presented in "HIV/AIDS Testing: World Review" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses

Biosensors in Medical Diagnostics - International Market Trends

press@researchandmarkets.com — Tue, 17 Nov 2009 10:36:05 GMT

Modern day sensors have come a long way from their predecessors, which used transistors made of bulky semi-conducting materials. Advent of micro fabrication technology has led to miniaturization of biosensors. Indeed under stages of development currently are nano-sized electronic components. However, biosensors market is characterized by slower pace of commercialization, which is primarily attributed to high cost, availability of effective alternative technologies, and issues related to stability, sensitivity, and quality assurance. Biosensors in medical applications remain a hugely untapped market, attracting several new players.

These and other market data and trends are presented in "Biosensors in Medical Diagnostics: International Market Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Genetic Testing - A Global Update of Market Trends & Opportunities

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:56 GMT

Genetic testing, which of-late has been transforming itself from service driven to product-driven market is expected to provide an impetus to diagnostic companies with respect to expansion of their operations. Genetic testing market has been witnessing a rise in demand from various quarters, which include medical, paternity & forensics departments, immigration & insurance sectors and DNA banks. Increasing emphasis on the need to develop new and more effective testing methods is projected to further propel the market growth. The early detection of genetic disorders using genetic testing would significantly reduce morbidity as well mortality rates.

These and other market data and trends are presented in "Genetic Testing: A Global Update of Market Trends & Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Molecular Diagnostics - A World Market Review

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:55 GMT

Molecular diagnostics market is being driven by several growth factors that include the need for automated and easy-to-handle techniques, which combine optimized sample preparation, analysis, and data evaluation, and the growing availability of molecular diagnostic tests for monitoring the therapeutic efficacy of expensive drugs. Additionally, the requirement of swift diagnoses techniques that would diagnose disease condition and medical disorders quickly and offer a strong and consistent tool for quick therapy decisions represents the other key factor. In terms of technological push, genomics and proteomics are the major drivers of the molecular diagnostic market. Nanobiotechnology and biochips are of key interest to the molecular diagnostics market.

Demand for molecular diagnostics and gene detection products is determined by the volume of tests performed in clinical labs, which continues to be miniscule in comparison to large battery of conventional diagnostic lab tests. However, provoked by the rate at which molecular tests is growing, companies are investing heavily in molecular diagnostics and gene detection systems to realize the potential in the offing.

These and other market data and trends are presented in "Molecular Diagnostics: A World Market Review" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Hemoglobin A1c Monitoring - Global Market Trends

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:55 GMT

The seriousness of affliction and the need for effective therapy to manage diabetes has led to the emergence of a significant market for monitoring the treatment efficiency of the disease. Other factors such as greater glucose control, product innovations that help improve compliance or convenience comprise other growth drivers in hemoglobin A1C monitoring market.

Diabetes patients (Type I) who regularly monitor their HbA1c (hemoglobin A1C) levels attain tight glucose control, thus considerably reducing their vulnerability to a cardiovascular disease. High blood sugar level for a longer period of time could result to increase in risk of heart disease or stroke. An HBA1C level more that 4.6 indicate the person is at increased risk for heart attack. The ADA (American Diabetes Association), recommends an HbA1c test every 3 to 6 months for monitoring the levels of blood sugar in insulin-administered patients, patients with high blood glucose levels and patients with a change of therapy.

These and other market data and trends are presented in "Hemoglobin A1c Monitoring: Global Market Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Growth Factors (Blood And Tissue) - A World Report

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:55 GMT

Age-related conditions such as Alzheimer's disease, malignancies, trauma and autoimmune disorders necessitate the development of less-invasive and more effective therapies. Growth factors (blood and tissue) have made an indelible mark on the market as a promising and cost-effective therapeutic solution for addressing unmet medical needs. Growth factors have a wide range of opportunities, especially in treating critical conditions such as granulocytopenia, leukemia, aplastic anaemia, bone marrow transplantation, and myelodysplastic syndrome. Additionally, human recombinant technologies have triggered these therapeutic biological products to greater heights.

These and other market data and trends are presented in "Growth Factors ( Blood And Tissue ): A World Report" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Cardiovascular Disease Diagnostics - A World Market Intelligence Report

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:53 GMT

World cardiovascular disease diagnostics market is primarily driven by development of enhanced diagnostics systems and procedures. Rising costs of materials and growing complexity of procedures characterize the field of cardiology today. Cardiovascular disease continues to remain the leading cause behind global mortality, resulting in tens of millions of deaths per annum. With the introduction of improved diagnostics, acute and chronic medications and surgical techniques, there has been a significant plunge in total cardiovascular disease mortality over the past few decades.

Worldwide cardiac diagnostic medical device market features intense competition triggered by rapid technology advancements and development initiatives. Increasing acceptance of Computed Tomography and Magnetic Resonance angiography is expected to modify cath-lab function. Today's cardiologists can contemplate the benefits of emerging 256-slice CT scanner technology. Imaging technologies are non-invasive and provide quicker diagnosis, which not only negates the requirement of invasive diagnostic techniques but also helps in early detection of the disease, especially in case of patients complaining undiagnosed acute chest pain.

These and other market data and trends are presented in "Cardiovascular Disease Diagnostics: A World Market Intelligence Report" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Developing Managed Care Pull-Through Excellence

press@researchandmarkets.com — Mon, 16 Nov 2009 09:26:25 GMT

In today's pharmaceutical marketplace, companies not only have to fight to win product placement on Managed Care formularies but also to ""pull through"" the business and increase market share after a win To benefit from formulary wins, savvy companies ensure that their sales forces and account...

Breast & Women's Imaging Seminar

press@researchandmarkets.com — Tue, 10 Nov 2009 14:45:46 GMT

This program is designed to provide radiologists and other breast and women’s imaging health care professionals with advances in the detection, diagnosis, management, and treatment of breast cancer and benign breast abnormalities Our focus will be on the impact of new technological advances and...

Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities

press@researchandmarkets.com — Mon, 02 Nov 2009 09:36:20 GMT

This cutting edge & insightful report can be used to interpret & assess the potential of RNAi-based medicines It provides opinions & market projections to: - assess the commercial potential of RNAi-based therapies in all of the key therapeutic areas: cancer, CNS disorders, viral infectious diseases,...

UK Molecular Diagnostics Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:43 GMT

This report presents a comprehensive analysis of the UK molecular diagnostics market, including:

Major issues pertaining to the UK molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
Ten-year test volume and reagent sales forecasts for the following categories:

   - Infectious Diseases

   - Genetic Diseases

   - Cancer

   - Paternity Testing/HLA Typing

   - Forensic Testing

Review of testing methodologies an instrumentation technologies.
Feature comparison of automated and semiautomated analyzers.
Sales and market shares of leading suppliers.
Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Business planning issues and concerns.

Contains 855 pages and 35 tables

Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:43 GMT

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry The next ten years will witness significant developments in reagent systems and automation, as well as the introduction of a wide range of new products that will require...

Spanish Molecular Diagnostics Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:43 GMT

This report presents a comprehensive analysis of the Spanish molecular diagnostics market, including:

Major issues pertaining to the Spanish molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
Ten-year test volume and reagent sales forecasts for the following categories:

   - Infectious DiseasesGenetic Diseases

   - Cancer

   - Paternity Testing/HLA Typing

   - Forensic Testing

Review of testing methodologies an instrumentation technologies.
Feature comparison of automated and semiautomated analyzers.
Sales and market shares of leading suppliers.
Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Business planning issues and concerns.

Contains 850 pages and 36 tables

Molecular Diagnostic Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:43 GMT

The report identifies over 60 specific new product development opportunities for molecular diagnostic instruments, consumables, and auxiliary products; proposes “ideal” product models with tentative prices and operating characteristics; and suggests alternative market penetration strategies for suppliers.Contains 22 pages

Molecular Diagnostic Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Analyzers

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:43 GMT

This report is designed to help suppliers identify and evaluate emerging opportunities for further automating molecular diagnostic methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the market, e.g., DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostic analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Tecan, Trinity Biotech and other manufacturers.Contains 20 pages

Molecular Diagnostic Applications for Forensic, Paternity and Disease Susceptibility Testing

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:42 GMT

The report presents an overview of the clinical significance and market needs for major forensic, paternity, disease susceptibility and other molecular diagnostic tests, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products.Contains 32 pages

Leading Molecular Diagnostics Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:42 GMT

The report presents insightful analyses of major current and emerging suppliers of molecular diagnostic products in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Contains 120 pages

Japanese Molecular Diagnostics Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:42 GMT

This report presents a comprehensive analysis of the Japanese molecular diagnostics market, including:

Major issues pertaining to the Japanese molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
Ten-year test volume and reagent sales forecasts for the following categories:

   - Infectious Diseases

   - Genetic Diseases

   - Cancer

   - Paternity Testing/HLA Typing

Forensic Testing

Review of testing methodologies an instrumentation technologies.
Feature comparison of automated and semiautomated analyzers.
Sales and market shares of leading suppliers.
Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Business planning issues and concerns.

Contains 860 pages and 36 tables

Italian Molecular Diagnostics Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:42 GMT

This report presents a comprehensive analysis of the Italian molecular diagnostics market, including:

Major issues pertaining to the Italian molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
Ten-year test volume and reagent sales forecasts for the following categories:

   - Infectious Diseases

   - Genetic Diseases

   - Cancer

   - Paternity Testing/HLA Typing

   - Forensic Testing

Review of testing methodologies an instrumentation technologies.
Feature comparison of automated and semiautomated analyzers.
Sales and market shares of leading suppliers.
Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Business planning issues and concerns.

Contains 850 pages and 36 tables

German Molecular Diagnostics Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:42 GMT

This report presents a comprehensive analysis of the German molecular diagnostics market, including:

Major issues pertaining to the German molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
Ten-year test volume and reagent sales forecasts for the following categories:

   - Infectious Diseases

   - Genetic Diseases

   - Cancer

   - Paternity Testing/HLA Typing

   - Forensic Testing

Review of testing methodologies an instrumentation technologies.
Feature comparison of automated and semiautomated analyzers.
Sales and market shares of leading suppliers.
Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Business planning issues and concerns.

Contains 850 pages and 36 tables

Genetic Diseases and Pharmacogenomics

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:42 GMT

The report presents an overview of the clinical significance and market needs for major genetic diseases, reviews the field of pharmacogenomics, and provides listings of companies developing and marketing molecular diagnostic technologies and products.Contains 75 pages and 1 table

French Molecular Diagnostics Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:41 GMT

This report presents a comprehensive analysis of the French molecular diagnostics market, including:

Major issues pertaining to the French molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
Ten-year test volume and reagent sales forecasts for the following categories:

   - Infectious Diseases

   - Genetic Diseases

   - Cancer

   - Paternity Testing/HLA Typing

   - Forensic Testing

Review of testing methodologies an instrumentation technologies.
Feature comparison of automated and semiautomated analyzers.
Sales and market shares of leading suppliers.
Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Business planning issues and concerns.

Contains 850 pages and 36 tables

DNA Sequencing: Role in Clinical Laboratories

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:41 GMT

Sequencing is expected to continue playing a major role in clinical laboratories, e.g., in detecting resistance mutations in viruses and bacteria, especially because of the rising availability of sequencing technologies and automated instrumentation.This report presents a concise review of the DNA sequencing field, including discussion of such topics as sequencing methods, automation, detection, gene profiling, and expression, polymorphism, screening, protein interaction networks, and others.

Contains 15 pages

Global Molecular Diagnostics Market: Facilities, Test Volumes, and Sales Forecasts by Country

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:41 GMT

This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as 5- and 10-year test volume and sales forecasts by country.Contains 15 pages and 4 tables

DNA and RNA Probes: Preparation, Formats, Labeling, Amplification, Detection

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:41 GMT

This comprehensive review of the DNA and RNA probe technology includes modern principles of probe preparation, various test formats, labeling techniques, and numerous amplification methods.Contains 60 pages

Cancer Molecular Diagnostic Testing

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:41 GMT

The report presents an overview of the clinical significance and market needs for major tumor markers, as well as listings of companies developing and marketing molecular diagnostic technologies and products for cancer testing.Contains 45 pages and 1 table

Biochips: Genosensors, Microarrays, Labs-On-The-Chip

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:41 GMT

Biochips, DNA Chips, Genosensors, Microarrays and Labs-on-the-Chip are extensions of biosensor and DNA technologies. They are increasingly used for mapping DNA clones in large genomic libraries; for sequencing stretches of DNA greater than a thousand bases per chip; for diagnosing infectious diseases, cancers, and genetic disorders; and for tissue typing, paternity testing, and fingerprinting applications. However, technical, manufacturing, quality control and cost issues continue to complicate their routine use. Also, diagnostic value of biochips may not be realized until genetic predisposition to heart disease, cancer, diabetes and several other conditions has been reliably established. The sequencing chips present an attractive business opportunity, and an enabling technology for broad-based genetic testing.Contains 15 pages

Infectious Disease Molecular Diagnostic Testing

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:40 GMT

The report presents an overview of the clinical significance and market needs for major infectious diseases, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products.Contains 360 pages and 20 tables

US Molecular Diagnostics Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:38 GMT

This report presents a comprehensive analysis of the US molecular diagnostics market, including:

Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
Ten-year test volume and reagent sales forecasts for the following categories:

   - Infectious Diseases

   - Genetic Diseases

   - Cancer

   - Paternity Testing/HLA Typing

   - Forensic Testing

Review of testing methodologies an instrumentation technologies.
Feature comparison of automated and semiautomated analyzers.
Sales and market shares of leading suppliers.
Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Business planning issues and concerns.

Contains 880 pages and 37 tables

Toshiba: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostic Imaging Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:30 GMT

A strategic assessment of Toshiba, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.Contains 116 pages and 10 tables

Siemens: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostic Imaging Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:30 GMT

A strategic assessment of Siemens, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.Contains 111 pages and 9 tables

Shimadzu: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostic Imaging Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:30 GMT

A strategic assessment of Shimadzu, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.Contains 65 pages and 6 tables

Philips: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostic Imaging Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:30 GMT

A strategic assessment of Philips, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.Contains 133 pages and 10 tables

Hologic: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostic Imaging Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:29 GMT

A strategic assessment of Hologic, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.Contains 49 pages and 6 tables

Hitachi: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostic Imaging Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:29 GMT

A strategic assessment of Hitachi, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.Contains 75 pages and 9 tables

GE: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostic Imaging Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:29 GMT

A strategic assessment of GE, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.Contains 127 pages and 9 tables

Esaote: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostic Imaging Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:28 GMT

A strategic assessment of Esaote, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.Contains 33 pages and 5 tables

Analogic: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostic Imaging Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:28 GMT

A strategic assessment of Analogic, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.Contains 49 pages and 7 tables

Aloka: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostic Imaging Market

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:28 GMT

A strategic assessment of Aloka, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.Contains 32 pages and 7 tables

Leading Diagnostics Imaging Companies Facilities and Employees

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:28 GMT

For each company, the analyses present:

Location and size of administrative, manufacturing, and R&D facilities in the U.S. and abroad.
New plants under construction.
U.S. and international work force size and distribution.

The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba.Contains 32 pages

Leading Diagnostic Imaging Companies Product Portfolio Analyses

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:28 GMT

For each company, the analyses present:

Placements and installed base of major systems in the U.S. and abroad, by modality.
Review of major product lines.
Specifications, features, advantages, weaknesses, introduction dates and prices of current systems.

The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba.Contains 230 pages

Leading Diagnostic Imaging Companies Technological Know-How

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:28 GMT

For each company, the report analyzes:

Internally developed and acquired diagnostic imaging and related technologies, including X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS, and others.

The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba.Contains 60 pages

Leading Diagnostic Imaging Companies R&D Expenditures and Major Programs

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:27 GMT

For each company, the report provides:

R&D budget, research facilities, and staff.
New technologies, systems, and applications in development, including their specifications and anticipated introduction dates.

The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba.Contains 40 pages

Leading Diagnostic Imaging Companies Organizations and Management

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:27 GMT

For each company, the report provides:

History of the imaging business evolution, which is important to understanding the company’s corporate culture and strategies.
Recent acquisitions, divestitures, and significant organizational changes.
Current organizational structure.
Management philosophy and attitudes toward the diagnostic imaging market.
Background of key executives.

The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba.Contains 92 pages

Leading Diagnostic Imaging Companies Financial Analyses

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:27 GMT

Each company’s analysis provides:

Sales estimates by division, geographic region, and modality.
Five-year sales and operating profit performance.

The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba.Contains 92 pages and 78 tables

Leading Diagnostic Imaging Companies Collaborations

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:27 GMT

For each company, the report analyzes:

Major joint venture, distribution, O.E.M., and licensing partners, both industrial and academic.
Terms of collaborative agreements and specific products involved.

The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba.Contains 82 pages

Leading Diagnostic Imaging Companies Comparative Analysis

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:27 GMT

This report ranks the world’s major diagnostic imaging companies according to the following criteria:

Sales and market shares in the U.S., Europe, Japan and other geographic regions.
Sales by modality.
Operating profit and margins.
R&D expenditures.

The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba.Contains 5 pages and 4 tables

Leading Diagnostic Imaging Companies Marketing Tactics

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:26 GMT

For each company, the analysis presents:

The U.S. and international sales force size in major geographic regions.
Selling options, including rental plans, leasing and others.
Promotional tactics, e.g., pricing, discounts, advertising, trade shows, seminars, product literature, newsletters, etc.
System service and support.

The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba.Contains 50 pages

Leading Diagnostic Imaging Companies Strategic Directions

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:26 GMT

For each company, the report provides insightful strategic assessments, including:

Business, new product development, and marketing strategies.
Anticipated acquisitions, joint ventures, and divestitures.

The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba.Contains 41 pages

Global Diagnostic Imaging Market Dynamics and Trends

press@researchandmarkets.com — Fri, 23 Oct 2009 14:30:26 GMT

A worldwide strategic overview of the diagnostic imaging market, including:

Estimates of the market size and growth.
Sales forecasts by geographic region and modality.
Review of the U.S. and international technological, regulatory, economic, demographic and social trends with potentially significant impact on the diagnostic imaging industry during the next five years.
Analysis of major geographic regions, including North America, Europe, Japan and Latin America.
Discussion of trends in X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS and other technologies.

Contains 34 pages and 3 tables

2009 Pathology Board Review Course

press@researchandmarkets.com — Thu, 15 Oct 2009 15:24:50 GMT

A comprehensive survey of current concepts and standards in pathology Why This Course is Different: The Oakstone Institute’s 2009 Pathology Board Review Course is a complete system that includes these extra-value features (included with your course fee): - Pretest to assess knowledge and gauge...

UK Wound Care Management Market Analysis and Forecasts to 2015

press@researchandmarkets.com — Tue, 13 Oct 2009 11:40:32 GMT

“UK Wound Care Management Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the global wound care management market The report provides market landscape, competitive landscape and market trends information on seven market categories including advanced wound...

US DNA-Based Diagnostic Test and Equipment Market Analysis & Directions

press@researchandmarkets.com — Mon, 12 Oct 2009 09:47:32 GMT

DNA-based diagnostics are established in laboratory medicine with many of the top tests run for infectious disease The U S market for DNA-based infectious disease tests is today a $1 1 billion industry Nucleic acid testing (NAT) is used to screen blood supplies; DNA-based tests are rapidly emerging...

Disruption or Advantage? Update on Companion Diagnostics

press@researchandmarkets.com — Wed, 30 Sep 2009 16:00:15 GMT

Some naysayers disagree, but we regard companion diagnostics as a win-win scenario for all stakeholders Companion diagnostics combines drug and diagnostic test development The potential for efficient drug development is huge because companion diagnostics can be used to predict drug response and...

Assessment of the Molecular Diagnostic Market for Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in UK

press@researchandmarkets.com — Tue, 22 Sep 2009 15:03:32 GMT

Hospital and private laboratories have been surveyed to collect information on NA tests performed, test volumes and used platforms and reagents. For data reliability and accurate projections at segment level a 3 step methodology has been applied:
Step 1: Identification of the total number of laboratories by secondary research and short telephone interviews with 561 hospitals to verify existence of internal laboratories.
Step 2: 355 laboratories in UK were classified for NAT activity and overall NA test volume.
Step 3: 36 laboratories provided data on NA test volume, kits, platforms and trends. A list of 44 NA tests have been provided to the labs for structured data entry. All data has been analysed and projected at total market level. Data is available by test and country.

Executive Summary

dii is an international marketing consulting company entirely specialised in healthcare markets providing market information and support to strategic market decisions. In cooperation with key industry a Continuous European Molecular Market Assessment has been realized in 2009 with the 2 main objectives:
1) Classification of laboratories by ownership, size and overall NA test volume
2) Market assessment for 44 NA tests on volumes, trends, kits and analyzers. All data is presented in Excel and PPT. Excel addresses all quantitative questions at segment level, including all volume projection scenarios and statistical detail, PPT presents the key data and provides an interpretation of general business implications

Assessment of the Molecular Diagnostic Market for VZV NA Tests in UK

press@researchandmarkets.com — Tue, 22 Sep 2009 15:03:32 GMT

Assessment of the Molecular Diagnostic Market for VRE NA Tests in UK